Structured Treatment Interruption: Approaches and Risks
- PMID: 11927050
- DOI: 10.1007/s11908-002-0059-2
Structured Treatment Interruption: Approaches and Risks
Abstract
Although highly active antiretroviral therapy suppresses HIV replication resulting in extraordinary clinical benefits, toxicity, adherence difficulties, and the monetary cost of medications limit the long-term effectiveness and availability of therapy for many HIV-infected individuals. Strategies to interrupt therapy have been proposed as a means to enhance the sustainability of antiretroviral treatment. Widely different approaches with varied patient populations, theoretical concepts, and clinical designs are frequently lumped together as "structured treatment interruptions." This review summarizes the approaches and risks of treatment interruptions in HIV infection. Currently, none of these strategies can be recommended in standard clinical practice.
Similar articles
-
Structured treatment interruption in patients infected with HIV: a new approach to therapy.Drugs. 2002;62(2):245-53. doi: 10.2165/00003495-200262020-00001. Drugs. 2002. PMID: 11817971 Review.
-
Structured treatment interruptions (STI) in chronic suppressed HIV infection in adults.Cochrane Database Syst Rev. 2005 Oct 19;(4):CD005482. doi: 10.1002/14651858.CD005482. Cochrane Database Syst Rev. 2005. PMID: 16235406 Review.
-
Risks and benefits of structured antiretroviral drug therapy interruptions in HIV-1 infection.AIDS. 2000 Oct 20;14(15):2313-22. doi: 10.1097/00002030-200010200-00012. AIDS. 2000. PMID: 11089619
-
Structured treatment interruptions for the management of HIV infection.JAMA. 2001 Dec 19;286(23):2981-7. doi: 10.1001/jama.286.23.2981. JAMA. 2001. PMID: 11743839 Review.
-
Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Verh K Acad Geneeskd Belg. 2001. PMID: 11813503 Review.
Cited by
-
Immunological responses and long-term treatment interruption after human immunodeficiency virus type 1 (HIV-1) lipopeptide immunization of HIV-1-infected patients: the LIPTHERA study.Clin Vaccine Immunol. 2008 Mar;15(3):562-8. doi: 10.1128/CVI.00165-07. Epub 2008 Jan 9. Clin Vaccine Immunol. 2008. PMID: 18184824 Free PMC article. Clinical Trial.
-
Structured treatment interruptions (STI) in chronic unsuppressed HIV infection in adults.Cochrane Database Syst Rev. 2006 Jul 19;2006(3):CD006148. doi: 10.1002/14651858.CD006148. Cochrane Database Syst Rev. 2006. PMID: 16856117 Free PMC article. Review.
-
CD8 T-Cell Responses before and after Structured Treatment Interruption in Ugandan Adults Who Initiated ART with CD4 T Cells <200 Cell/μL: The DART Trial STI Substudy.AIDS Res Treat. 2011;2011:875028. doi: 10.1155/2011/875028. Epub 2011 Jan 18. AIDS Res Treat. 2011. PMID: 21490785 Free PMC article.
-
Correlates of unstructured antiretroviral treatment interruption in a cohort of HIV-positive individuals in British Columbia.AIDS Behav. 2014 Nov;18(11):2240-8. doi: 10.1007/s10461-014-0776-1. AIDS Behav. 2014. PMID: 24781638 Free PMC article.
-
Randomized, controlled trial of therapy interruption in chronic HIV-1 infection.PLoS Med. 2004 Dec;1(3):e64. doi: 10.1371/journal.pmed.0010064. Epub 2004 Dec 28. PLoS Med. 2004. PMID: 15630469 Free PMC article. Clinical Trial.
References
LinkOut - more resources
Full Text Sources